Article
Metabolism-oriented compound screen in physiological culture conditions identifies a NAMPT…
medRxiv · 2024 · Preis, J. R.; Rolvering, C.; Kirchmeyer, M.; Kreis, S.; Behrmann, I.; Haan, C.
Key facts
| Title | Metabolism-oriented compound screen in physiological culture conditions identifies a NAMPT inhibitor highly effective against drug-naive and -resistant melanoma cells |
|---|---|
| First author | Preis, J. R.; Rolvering, C.; Kirchmeyer, M.; Kreis, S.; Behrmann, I.; Haan, C. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.10.23.619802 |
| Devices mentioned | BK110039, DEN000008, K022086, K822496 |
| Product codes mentioned | JCI, KIT, NDS, JIT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1